Chat with us, powered by LiveChat
Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     PAYMENT LINK _ Drug Discovery Services Market by Process (Target Selection, Hit-to-Lead Identification, Lead Optimization), Type (Medicinal Chemistry, Biology Services, DMPK), Drug Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, Neurology) - Forecast to 2022     Global Transdermal Drug Delivery Systems Market     Active    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

European Active Transdermal Drug Delivery Devices Market Research Report

  • Report Code: AC 1002
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The European active transdermal drug delivery devices market, mainly driven by patent cliffs, increased incidence of chronic diseases, increasing competition, improving patient compliance, reformulation and repositioning of drugs using advanced oral delivery systems, and huge investment made by major pharmaceutical companies, was valued at $353.0 million in 2013, and expected to reach $633.0 million by 2018, at a CAGR of 12.4%.

 

The report ‘European Active Transdermal Drug Delivery Devices Market forecast, 2012-2018’ analyzes the market by segments, namely active transdermal drug delivery and passive transdermal drug delivery.

 

Europe holds the second position, in terms of value, in the overall transdermal drug delivery devices market. The European market is segmented by five major countries, namely Germany, France, the U.K., Italy, and Spain.

 

The report also provides an extensive competitive landscaping of companies operating in the active transdermal drug delivery devices market, namely Novartis, Johnson & Johnson, 3M Company, and Noven.

 

Segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.

 

Customization Options

Along with the market data, you can also customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep-dive analysis of the following parameters:

 

Product Analysis

  • Usage pattern (in-depth trend analysis) of  products (segment-wise)
  • Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
  • End-user adoption rate analysis of the products (segment-wise and country-wise)
  • Comprehensive coverage of product approvals, pipeline products, and product recalls

 

Pharmacists Forum

  • Fast turn-around analysis of pharmacists’ response to market events and trends
  • Pharmacists’ opinion about active transdermal drug delivery devices products from different companies
  • Pharmacists’ qualitative inputs on epidemiology data
  • Pattern analysis of usage of drugs by physicians

 

Brand/Product Perception Matrix

  • Comprehensive study of customers perception and behavior through our in-built social connect tool checking the virality and tonality of blogs
  • Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)


1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview

Please fill in the form below to receive a free copy of the Summary of this Report
















European Active Transdermal Drug Delivery Devices Market Research Report

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
North American Transdermal Drug Delivery Systems Market North American Transdermal Drug Delivery Systems Market
The North American Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies.The Market was Valued at $7.6 billion in 2013 and expected to be $12.7 billion by 2018, growing at a CAGR of 10.9%. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
European Transdermal Drug Delivery Systems Market European Transdermal Drug Delivery Systems Market
The European Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies.The Market was Valued at $3.6 billion in 2013 and expected to be $5.8 billion by 2018, growing at a CAGR of 9.9 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
Asian Transdermal Drug Delivery Systems Market Asian Transdermal Drug Delivery Systems Market
The Asian Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies.The Market was Valued at $1.5 billion in 2013 and expected to be $3.0 billion by 2018, growing at a CAGR of 14.8 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
of items
reports | Show
Connect With Us
US/CAN : +1-888-502-0539
European Active Transdermal Drug Delivery Devices Market